{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:25:33Z","timestamp":1793330733723,"version":"4.5.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,29]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Patients with acute leukemias harboring translocations involving gene lysine methyltransferase 2A (KMT2A) have a poor prognosis due to chemotherapy resistance with rapid relapse following standard treatments. The resulting KMT2A fusion proteins dysregulate gene expression, leading to an upregulation of leukemogenic transcription factors such as HOXA9 and MEIS1, which drives leukemic transformation. Although menin inhibitors are proving to be promising new therapeutics for patients with KMT2A-rearranged (KMT2Ar) acute leukemia, resistance mechanisms have already been described and new therapeutic approaches for this patient subgroup must be identified. Here, a genome-wide CRISPR\/Cas9 screen in a KMT2Ar B-cell acute lymphoblastic leukemia cell line identified the deubiquitinase ubiquitin-specific peptidase 22 (USP22) as a novel regulator of MEIS1 protein stability. USP22 is a member of the Spt-Ada-Gcn5 acetyltransferase multiprotein complex, which has crucial functions in shaping the chromatin landscape and modulating transcription. Genetic depletion of USP22 impaired cellular growth and proliferation in KMT2Ar acute leukemia models. Chromatin immunoprecipitation revealed cooperative binding between USP22 and MEIS1 at critical oncogenic target genes, suggesting that USP22 safeguards leukemogenic transcription by protecting MEIS1 from proteasomal degradation. Genetic or chemical inhibition of USP22 led to the polyubiquitination of MEIS1, resulting in proteasomal degradation and downregulation of the expression of target genes. Our study identifies USP22 as a novel regulator of MEIS1 protein stability that could potentially be exploited as a therapeutic target in the future in KMT2Ar leukemias.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031845","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:59:09Z","timestamp":1783537149000},"page":"2251-2263","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in\n                    <i>KMT2Ar<\/i>\n                    acute leukemia"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5581-3461","authenticated-orcid":false,"given":"Sarah","family":"Br\u00f6chtel","sequence":"first","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0092-5999","authenticated-orcid":false,"given":"Constanze","family":"Schneider","sequence":"additional","affiliation":[{"name":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology\/Oncology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"4The Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3525-8056","authenticated-orcid":false,"given":"Marius","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Villinger","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Plenge","sequence":"additional","affiliation":[{"name":"5Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Gupta","sequence":"additional","affiliation":[{"name":"5Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Immanuel","family":"Kesel","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Scheich","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"},{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9993-9750","authenticated-orcid":false,"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7262-5534","authenticated-orcid":false,"given":"Ali Yavuz","family":"Cakir","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"H\u00e4upl","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"},{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"},{"name":"7German Cancer Research Center, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5587-6761","authenticated-orcid":false,"given":"Florian","family":"B\u00fcttner","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"},{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5995-6494","authenticated-orcid":false,"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"},{"name":"8Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe University, Frankfurt am Main, Germany"},{"name":"9Structure Genomics Consortium, Buchmann Institute for Molecular Life Sciences, Johann Wolfgang Goethe University, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-5516","authenticated-orcid":false,"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"},{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Stegmaier","sequence":"additional","affiliation":[{"name":"3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Division of Hematology\/Oncology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA"},{"name":"4The Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-3321","authenticated-orcid":false,"given":"Florian","family":"Perner","sequence":"additional","affiliation":[{"name":"5Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Oellerich","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"},{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"},{"name":"7German Cancer Research Center, Heidelberg, Germany"},{"name":"10University Cancer Center, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Cremer","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Hematology\/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany"},{"name":"2Frankfurt Cancer Institute, Frankfurt am Main, Germany"},{"name":"6German Cancer Consortium, partner site Frankfurt\/Mainz, a partnership between German Cancer Research Center and University Cancer Center Frankfurt-Marburg, Frankfurt am Main, Germany"},{"name":"10University Cancer Center, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10393","key":"2026102911214253100_bib1","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"issue":"7","key":"2026102911214253100_bib2","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ajh.27708","article-title":"Adult acute lymphoblastic leukemia: 2025 update on diagnosis, therapy, and monitoring","volume":"100","author":"Kantarjian","year":"2025","journal-title":"Am J Hematol"},{"issue":"9","key":"2026102911214253100_bib3","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N Engl J Med"},{"issue":"14","key":"2026102911214253100_bib4","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2017-08-798322","article-title":"Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia","volume":"131","author":"Gokbuget","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2026102911214253100_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am J Hematol"},{"issue":"1","key":"2026102911214253100_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood.2023022481","article-title":"How I treat refractory and relapsed acute myeloid leukemia","volume":"143","author":"Thol","year":"2024","journal-title":"Blood"},{"issue":"12","key":"2026102911214253100_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"issue":"16","key":"2026102911214253100_bib8","doi-asserted-by":"crossref","first-page":"9023","DOI":"10.3390\/ijms25169023","article-title":"KMT2A rearrangements in leukemias: molecular aspects and therapeutic perspectives","volume":"25","author":"Guarnera","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2026102911214253100_bib9","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"issue":"12","key":"2026102911214253100_bib10","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3390\/cimb47120988","article-title":"Research progress on the KMT2A-AFF3 fusion gene in childhood acute lymphoblastic leukemia: mechanisms, clinical implications, and therapeutic strategies","volume":"47","author":"Zhang","year":"2025","journal-title":"Curr Issues Mol Biol"},{"issue":"3","key":"2026102911214253100_bib11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol Cell"},{"issue":"8","key":"2026102911214253100_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1182\/blood.2023021234","article-title":"Transcriptional control of leukemogenesis by the chromatin reader SGF29","volume":"143","author":"Barbosa","year":"2024","journal-title":"Blood"},{"issue":"2","key":"2026102911214253100_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ijc.35332","article-title":"Targeting the menin-KMT2A interaction in leukemia: lessons learned and future directions","volume":"158","author":"Perner","year":"2026","journal-title":"Int J Cancer"},{"issue":"10","key":"2026102911214253100_bib14","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1158\/2159-8290.CD-24-1517","article-title":"Catalytic inhibition of KAT6\/KAT7 enhances the efficacy and overcomes primary and acquired resistance to menin inhibitors in MLL leukemia","volume":"15","author":"Gordon","year":"2025","journal-title":"Cancer Discov"},{"issue":"15","key":"2026102911214253100_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.2023021105","article-title":"Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML","volume":"143","author":"Bourgeois","year":"2024","journal-title":"Blood"},{"issue":"6","key":"2026102911214253100_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccell.2019.11.001","article-title":"A menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia","volume":"36","author":"Krivtsov","year":"2019","journal-title":"Cancer Cell"},{"issue":"7954","key":"2026102911214253100_bib17","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41586-023-05755-9","article-title":"MEN1 mutations mediate clinical resistance to menin inhibition","volume":"615","author":"Perner","year":"2023","journal-title":"Nature"},{"issue":"7954","key":"2026102911214253100_bib18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"issue":"12","key":"2026102911214253100_bib19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s41594-021-00682-7","article-title":"Structure of the human SAGA coactivator complex","volume":"28","author":"Herbst","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"2026102911214253100_bib20","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/ijms24043219","article-title":"Ubiquitin-specific proteases (USPs) and metabolic disorders","volume":"24","author":"Kitamura","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026102911214253100_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat Genet"},{"issue":"11","key":"2026102911214253100_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2026102911214253100_bib23","doi-asserted-by":"crossref","first-page":"1589729","DOI":"10.3389\/fimmu.2025.1589729","article-title":"Strategies for CRISPR-based knock-ins in primary human B cells and lymphoma cell lines","volume":"16","author":"Lund","year":"2025","journal-title":"Front Immunol"},{"issue":"2","key":"2026102911214253100_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2026102911214253100_bib25","doi-asserted-by":"crossref","first-page":"109739","DOI":"10.1016\/j.celrep.2021.109739","article-title":"DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation","volume":"36","author":"Song","year":"2021","journal-title":"Cell Rep"},{"issue":"2","key":"2026102911214253100_bib26","doi-asserted-by":"crossref","first-page":"e87646","DOI":"10.1371\/journal.pone.0087646","article-title":"Homeodomain transcription factor Meis1 is a critical regulator of adult bone marrow hematopoiesis","volume":"9","author":"Ariki","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2026102911214253100_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/jdb9040044","article-title":"MEIS1 in hematopoiesis and cancer. How MEIS1-PBX interaction can be used in therapy","volume":"9","author":"Blasi","year":"2021","journal-title":"J Dev Biol"},{"key":"2026102911214253100_bib28","doi-asserted-by":"crossref","first-page":"217196","DOI":"10.1016\/j.canlet.2024.217196","article-title":"Hepatocyte growth factor promotes melanoma metastasis through ubiquitin-specific peptidase 22-mediated integrins upregulation","volume":"604","author":"Gao","year":"2024","journal-title":"Cancer Lett"},{"issue":"31","key":"2026102911214253100_bib29","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1111\/1759-7714.15439","article-title":"USP22 promotes gefitinib resistance and inhibits ferroptosis in non-small cell lung cancer by deubiquitination of MDM2","volume":"15","author":"Lu","year":"2024","journal-title":"Thorac Cancer"},{"issue":"1","key":"2026102911214253100_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","article-title":"Control of protein stability by post-translational modifications","volume":"14","author":"Lee","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"2026102911214253100_bib31","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3390\/cancers13102497","article-title":"Cyclin-dependent kinase inhibitors in hematological malignancies-current understanding, (pre-)clinical application and promising approaches","volume":"13","author":"Richter","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2026102911214253100_bib32","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1002\/jcp.25841","article-title":"Deubiquitinating enzyme USP22 positively regulates c-myc stability and tumorigenic activity in mammalian and breast cancer cells","volume":"232","author":"Kim","year":"2017","journal-title":"J Cell Physiol"},{"issue":"6","key":"2026102911214253100_bib33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.201112098","article-title":"A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells","volume":"196","author":"Roux","year":"2012","journal-title":"J Cell Biol"},{"issue":"5","key":"2026102911214253100_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nbt0502-473","article-title":"Protein detection using proximity-dependent DNA ligation assays","volume":"20","author":"Fredriksson","year":"2002","journal-title":"Nat Biotechnol"},{"issue":"24","key":"2026102911214253100_bib35","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1101\/gad.1741408","article-title":"Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia","volume":"22","author":"Guenther","year":"2008","journal-title":"Genes Dev"},{"issue":"47","key":"2026102911214253100_bib36","doi-asserted-by":"crossref","first-page":"eabo4116","DOI":"10.1126\/sciadv.abo4116","article-title":"A deubiquitination module essential for T(reg) fitness in the tumor microenvironment","volume":"8","author":"Montauti","year":"2022","journal-title":"Sci Adv"},{"key":"2026102911214253100_bib37","doi-asserted-by":"crossref","first-page":"918314","DOI":"10.3389\/fimmu.2022.918314","article-title":"Immune evasion and drug resistance mediated by USP22 in cancer: novel targets and mechanisms","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"2026102911214253100_bib38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI23412","article-title":"Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer","volume":"115","author":"Glinsky","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"2026102911214253100_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-024-01894-8","article-title":"USP22 regulates APL differentiation via PML-RAR\u03b1 stabilization and IFN repression","volume":"10","author":"Kowald","year":"2024","journal-title":"Cell Death Discov"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/18\/2251\/2597049\/blood_bld-2025-031845-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/18\/2251\/2597049\/blood_bld-2025-031845-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:21:54Z","timestamp":1793287314000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/18\/2251\/569597\/USP22-is-a-novel-vulnerability-regulating-MEIS1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,29]]},"references-count":39,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2026,10,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031845","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,29]]},"published":{"date-parts":[[2026,10,29]]}}}